Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
6. |
ECCT/24/10/02 | user abstract 123 |
Principal Investigator(s) 1. Irene Peterson Melinda Farrell Marah Bush Site(s) in Kenya 1. Harriet Battle (Kirinyaga county) |
View |
7. |
ECCT/24/11/02 | Iusto obcaecati Nam dicta veli Clinical trials are research studies conducted with human participants to evaluate the safety, effectiveness, and potential side effects of medical interventions, such as new drugs, devices, or therapies. These trials are essential for advancing medical knowledge and ensuring treatments meet rigorous standards. By following a structured approach, clinical trials provide a systematic way to assess new interventions before they are widely adopted in healthcare. The process of clinical trials typically progresses through multiple phases. Early phases focus on determining safety and optimal dosing in smaller groups, while later phases assess the efficacy and broader application of the intervention in larger populations. This phased approach ensures that each stage addresses specific scientific and medical questions, gradually building a comprehensive understanding of the intervention's impact. Ethical guidelines and scientific rigor are crucial in clinical trials to protect participants and maintain public trust. Researchers adhere to principles like informed consent and beneficence while ensuring trials are inclusive and unbiased. By bridging the gap between laboratory research and real-world medical practice, clinical trials play a critical role in improving healthcare outcomes globally. |
Principal Investigator(s) 1. Linus Sexton Ori Hill Jacob Mckay Site(s) in Kenya 1. |
View |
8. |
ECCT/24/06/01 | Ut qui nulla ut recusandae Om Clinical trials are systematic investigations conducted in human participants to evaluate the safety, efficacy, and overall therapeutic value of medical interventions, including drugs, medical devices, and treatment regimens. These trials are a critical phase in the drug development process, providing essential data that informs regulatory approvals, clinical practice, and patient care. Clinical trials are typically conducted in several phases, each designed to answer specific research questions and build upon the knowledge gained from previous phases: Phase I focuses on assessing the safety and tolerability of a new intervention in a small group of healthy volunteers or patients. This phase aims to determine the appropriate dosage range and identify any potential side effects. Phase II involves a larger group of patients and aims to provide preliminary data on the intervention's efficacy while continuing to monitor its safety. This phase helps to refine dosing and further assess the intervention's therapeutic potential. Phase III trials are expanded to a larger patient population and are designed to confirm the intervention's efficacy, monitor side effects, and compare it to standard or placebo treatments. Successful completion of Phase III is often required for regulatory approval. Phase IV trials, conducted after a drug has been approved and marketed, gather additional information on the intervention's long-term safety, effectiveness, and optimal use. These post-marketing studies help identify any rare or long-term adverse effects and ensure the intervention's continued benefit to patients. The design and conduct of clinical trials are governed by stringent ethical and scientific standards to ensure the protection of participants and the integrity of the data collected. This includes obtaining informed consent, ensuring randomization and blinding where applicable, and conducting rigorous statistical analysis. Clinical trials provide the foundation for evidence-based medicine, driving advancements in healthcare and enabling the development of new and improved treatments. The data generated from these trials not only supports regulatory decision-making but also informs clinical guidelines and helps shape future research directions, ultimately contributing to improved patient outcomes and public health. |
Principal Investigator(s) 1. Signe Stein Basil Goodman Isaac Hughes Site(s) in Kenya 1. Linus Dotson (Wajir county) 2. ssss (Kajiado county) 3. ewewqwsa (Busia county) 4. qwerfdsa (Bung\'oma county) 5. qwqwqwq (Kakamega county) 6. qwedsaqwe (Kakamega county) 7. wwww (Homa Bay county) 8. qwerfdsa (Elgeyo/Marakwet county) 9. qwedsa (Elgeyo/Marakwet county) 10. erfdsewq (Kakamega county) 11. rttfjhkjfhashfkj (Elgeyo/Marakwet county) 12. kfkjfkljflkjflk (Embu county) 13. iourioreuroiruiorerue (Homa Bay county) 14. ioreuioreuioreurerew (Bomet county) 15. iouioruriouiroori (Embu county) 16. ioreuioreuiruroir (Isiolo county) 17. dlkjfklajfkljlka (Embu county) |
View |
9. |
ECCT/24/06/01 - WERTY | Ut qui nulla ut recusandae Om Clinical trials are systematic investigations conducted in human participants to evaluate the safety, efficacy, and overall therapeutic value of medical interventions, including drugs, medical devices, and treatment regimens. These trials are a critical phase in the drug development process, providing essential data that informs regulatory approvals, clinical practice, and patient care. Clinical trials are typically conducted in several phases, each designed to answer specific research questions and build upon the knowledge gained from previous phases: Phase I focuses on assessing the safety and tolerability of a new intervention in a small group of healthy volunteers or patients. This phase aims to determine the appropriate dosage range and identify any potential side effects. Phase II involves a larger group of patients and aims to provide preliminary data on the intervention's efficacy while continuing to monitor its safety. This phase helps to refine dosing and further assess the intervention's therapeutic potential. Phase III trials are expanded to a larger patient population and are designed to confirm the intervention's efficacy, monitor side effects, and compare it to standard or placebo treatments. Successful completion of Phase III is often required for regulatory approval. Phase IV trials, conducted after a drug has been approved and marketed, gather additional information on the intervention's long-term safety, effectiveness, and optimal use. These post-marketing studies help identify any rare or long-term adverse effects and ensure the intervention's continued benefit to patients. The design and conduct of clinical trials are governed by stringent ethical and scientific standards to ensure the protection of participants and the integrity of the data collected. This includes obtaining informed consent, ensuring randomization and blinding where applicable, and conducting rigorous statistical analysis. Clinical trials provide the foundation for evidence-based medicine, driving advancements in healthcare and enabling the development of new and improved treatments. The data generated from these trials not only supports regulatory decision-making but also informs clinical guidelines and helps shape future research directions, ultimately contributing to improved patient outcomes and public health. |
Principal Investigator(s) 1. Signe Stein Basil Goodman Isaac Hughes Site(s) in Kenya 1. Linus Dotson (Wajir county) 2. ssss (Kajiado county) 3. ewewqwsa (Busia county) 4. qwerfdsa (Bung\'oma county) 5. qwqwqwq (Kakamega county) 6. qwedsaqwe (Kakamega county) 7. wwww (Homa Bay county) 8. qwerfdsa (Elgeyo/Marakwet county) 9. qwedsa (Elgeyo/Marakwet county) 10. erfdsewq (Kakamega county) 11. rttfjhkjfhashfkj (Elgeyo/Marakwet county) 12. kfkjfkljflkjflk (Embu county) 13. iourioreuroiruiorerue (Homa Bay county) 14. ioreuioreuioreurerew (Bomet county) 15. iouioruriouiroori (Embu county) 16. ioreuioreuiruroir (Isiolo county) 17. dlkjfklajfkljlka (Embu county) |
View |
10. |
ECCT/24/06/05 | Study 3 Efficacy and Safety of Novel Immunotherapy in Treating Advanced Melanoma: A Randomized Controlled Tria |
Principal Investigator(s) 1. Javan Ayoma Site(s) in Kenya Site1 |
View |
